Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue

Area of Science:

• Neuroscience
• Cell Biology
• Developmental Biology

Background:

• Platelet-activating factor (PAF) is a signaling molecule in the brain involved in neural functions.
• PAF is implicated in Miller-Dieker Lissencephaly (MDL), a human developmental brain disorder.
• PAF exposure causes rapid, reversible changes in cultured hippocampal neurites, including growth cone collapse and neurite retraction.

Purpose of the Study:

• To investigate the cytoskeletal alterations underlying PAF-induced neurite shape changes.
• To compare the effects of methyl carbamyl PAF (mc-PAF) with other cytoskeletal-altering drugs.

Main Methods:

• Utilized fluorescent labeling of cytoskeletal proteins (microtubules and F-actin) and mitochondria.
• Employed electron microscopy (EM) for detailed ultrastructural analysis.
• Compared mc-PAF effects with nocodazole (MT-depolymerizing) and taxol (MT-stabilizing) treatments.

Main Results:

• mc-PAF induced rearrangements of microtubules (MTs), F-actin, and mitochondria.
• MT splaying and unbundling occurred in neurite varicosities after mc-PAF treatment.
• F-actin redistributed from the growth cone to the neurite shaft, and mitochondria showed retrograde movement and aggregation.

Conclusions:

• Cytoskeletal rearrangements involving MTs, F-actin, and mitochondria mediate PAF-induced neurite shape changes.
• Taxol pre-incubation blocked mc-PAF effects, indicating a role for MT stabilization.
• Findings provide insights into PAF's influence on neuronal activity and potential relevance to MDL impairments in neuronal motility.